Stocks News

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP, from 19 hours ago by Dow Jones
  19 hours ago by Dow Jones
  Companies Mentioned: SNY
  
  Rilzabrutinib is an oral, reversible, covalent BTK inhibitor that has the potential to be a first- and best-in-class treatment of several immune-mediated and inflammatory diseases. BTK, expressed in B cells, macrophages, and other immune cells, plays a critical role in inflammatory pathways and multiple immune-mediated disease processes. With the application of Sanofi's TAILORED COVALENCY(R) technology, rilzabrutinib can selectively inhibit the BTK target while potentially reducing the risk of off-target side effects.
Dec 6, 2024
- Press Release: Availability of the revised financial statements for Sanofi excluding Opella, from 1:30AM ET on Friday Dec 06, 2024 by Dow Jones
  1:30AM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  Press Release: Availability of the revised financial statements for Sanofi excluding Opella
  
  Availability of the revised financial statements for Sanofi excluding Opella
Dec 3, 2024
- DJ Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China, from 12:35AM ET on Tuesday Dec 03, 2024 by Dow Jones
  12:35AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  By Kimberley Kao
  
  Sanofi plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company's largest single investment in the world's second-largest economy.
Nov 29, 2024
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
  08:09 AM EST, 11/29/2024 (MT Newswires) -- Astrazeneca (AZN) confirmed Friday in an emailed statement to MT Newswires that its breast cancer treatment Enhertu and cancer treatment Orpathys have been added to China's National Reimbursement Drug List ...
Nov 25, 2024
- DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 4:15AM ET on Monday Nov 25, 2024 by Dow Jones
  4:15AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  0914 GMT - Sanofi's revised hospital drug-discount program in the U.S. holds long-term promise, although industry-wide implementation hurdles persist, Bryan Garnier Health analysts say in a note. The U.S. federal program, known as 340B and aimed at vulnerable patients, is increasingly used by hospitals to profit by charging the drugs' list prices while purchasing them at a discount, the analysts say. Under its new plan, Sanofi requires institutions to provide medical claims information before receiving discounts. Eli Lilly and Johnson & Johnson this month sued the federal government for rejecting similar rebate proposals. Sanofi reported in 2023 that discounts under Medicare and 340B led to a 15.7% decrease in its portfolio net price. Shares fall 0.3% to 92.89 euros. (helena.smolak@wsj.com)

Dec 6, 2024
- DJ AstraZeneca PLC Stock Rises Friday, Outperforms Market, from 12:01PM ET on Friday Dec 06, 2024 by Dow Jones
  12:01PM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: AZN
- Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of Eagerly Awaited Employment Situation Report, from 8:25AM ET on Friday Dec 06, 2024 by MT Newswires
  8:25AM ET on Friday Dec 06, 2024 by MT Newswires
  Companies Mentioned: GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, QQQ, SPY, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, XSD, BY, RTH, USO, DOCU, SLV, XRT, EXI, AZN, DOOO, PFIE, BITO, GFR, UNG, CECO, EEM
- AstraZeneca's Imfinzi Granted Priority Review in US as Muscle-Invasive Bladder Cancer Treatment, from 7:35AM ET on Friday Dec 06, 2024 by MT Newswires
  7:35AM ET on Friday Dec 06, 2024 by MT Newswires
  Companies Mentioned: AZN
- AZN STOCK ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of an Ongoing Investigation, from 7:30AM ET on Friday Dec 06, 2024 by Accesswire
  7:30AM ET on Friday Dec 06, 2024 by Accesswire
  Companies Mentioned: AZN
- AZN STOCK ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of an Ongoing Investigation, from 7:30AM ET on Friday Dec 06, 2024 by Dow Jones
  7:30AM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: AZN
- AstraZeneca Says Dato-DXd Shows 'Clinically Meaningful' Results in Previously Treated Lung Cancer, from 7:29AM ET on Friday Dec 06, 2024 by MT Newswires
  7:29AM ET on Friday Dec 06, 2024 by MT Newswires
  Companies Mentioned: AZN
- IMFINZI(R) (durvalumab) granted Priority Review in the US for patients with muscle-invasive bladder cancer, from 7:00AM ET on Friday Dec 06, 2024 by Dow Jones
  7:00AM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: AZN
Dec 5, 2024
- Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS, from 5:06PM ET on Thursday Dec 05, 2024 by Dow Jones
  5:06PM ET on Thursday Dec 05, 2024 by Dow Jones
  Companies Mentioned: PFE
- Sector Update: Health Care Stocks Retreat Late Afternoon, from 3:49PM ET on Thursday Dec 05, 2024 by MT Newswires
  3:49PM ET on Thursday Dec 05, 2024 by MT Newswires
  Companies Mentioned: LLY, NVO, PFE, TARA
- Market Chatter: Eli Lilly, Pfizer Executives Discuss Cancer Cures With President-Elect Trump, from 2:38PM ET on Thursday Dec 05, 2024 by MT Newswires
  2:38PM ET on Thursday Dec 05, 2024 by MT Newswires
  Companies Mentioned: LLY, PFE

Sanofi SA
NASDAQ:SNYUnited States

Search Criteria

Yesterday

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP, from 19 hours ago by Dow Jones

Dec 6, 2024

Press Release: Availability of the revised financial statements for Sanofi excluding Opella, from 1:30AM ET on Friday Dec 06, 2024 by Dow Jones

Dec 3, 2024

DJ Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China, from 12:35AM ET on Tuesday Dec 03, 2024 by Dow Jones

Nov 29, 2024

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires

Nov 25, 2024

DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 4:15AM ET on Monday Nov 25, 2024 by Dow Jones

Peers Headlines

Dec 6, 2024

DJ AstraZeneca PLC Stock Rises Friday, Outperforms Market, from 12:01PM ET on Friday Dec 06, 2024 by Dow Jones

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of Eagerly Awaited Employment Situation Report, from 8:25AM ET on Friday Dec 06, 2024 by MT Newswires

AstraZeneca's Imfinzi Granted Priority Review in US as Muscle-Invasive Bladder Cancer Treatment, from 7:35AM ET on Friday Dec 06, 2024 by MT Newswires

AZN STOCK ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of an Ongoing Investigation, from 7:30AM ET on Friday Dec 06, 2024 by Accesswire

AZN STOCK ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of an Ongoing Investigation, from 7:30AM ET on Friday Dec 06, 2024 by Dow Jones

AstraZeneca Says Dato-DXd Shows 'Clinically Meaningful' Results in Previously Treated Lung Cancer, from 7:29AM ET on Friday Dec 06, 2024 by MT Newswires

IMFINZI(R) (durvalumab) granted Priority Review in the US for patients with muscle-invasive bladder cancer, from 7:00AM ET on Friday Dec 06, 2024 by Dow Jones

Dec 5, 2024

Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS, from 5:06PM ET on Thursday Dec 05, 2024 by Dow Jones

Sector Update: Health Care Stocks Retreat Late Afternoon, from 3:49PM ET on Thursday Dec 05, 2024 by MT Newswires

Market Chatter: Eli Lilly, Pfizer Executives Discuss Cancer Cures With President-Elect Trump, from 2:38PM ET on Thursday Dec 05, 2024 by MT Newswires